DK2211873T3 - Stabil, amorf calciumcarbonat, der omfatter phosphorylerede aminosyrer - Google Patents

Stabil, amorf calciumcarbonat, der omfatter phosphorylerede aminosyrer

Info

Publication number: DK2211873T3
Authority: DK; Denmark
Prior art keywords: stable; amino acids; calcium carbonate; amorphous calcium; phosphorylated amino
Prior art date: 2007-10-22

Application number

DK08842462.7T

Other languages

English (en)

Inventor

Shmuel Bentov

Amir Sagi

Amir Berman

Assaf Shechter

Original Assignee

Amorphical Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-10-22

Filing date

2008-10-22

Publication date

2012-11-19

2007-10-22 Priority claimed from IL186850A external-priority patent/IL186850A/en

2008-08-14 Priority claimed from IL193461A external-priority patent/IL193461A/en

2008-10-22 Application filed by Amorphical Ltd filed Critical Amorphical Ltd

2012-11-19 Application granted granted Critical

2012-11-19 Publication of DK2211873T3 publication Critical patent/DK2211873T3/da

Links

VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 title 2
150000001413 amino acids Chemical class 0.000 title 1
229910000019 calcium carbonate Inorganic materials 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Immunology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Inorganic Chemistry (AREA)
Insects & Arthropods (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Tropical Medicine & Parasitology (AREA)
Obesity (AREA)
Diabetes (AREA)
Hematology (AREA)
Nutrition Science (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)

DK08842462.7T 2007-10-22 2008-10-22 Stabil, amorf calciumcarbonat, der omfatter phosphorylerede aminosyrer DK2211873T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IL186850A IL186850A (en)	2007-10-22	2007-10-22	Steady amorphous calcium carbonate containing phosphorylated amino acids, phosphorylated synthetic peptides and gastric proteins
IL193461A IL193461A (en)	2008-08-14	2008-08-14	Stable amorphous calcium carbonate containing phosphorylated amino acids and the use of pharmaceutical and nutritional preparations
PCT/IL2008/001362 WO2009053967A1 (en)	2007-10-22	2008-10-22	Stable amorphous calcium carbonate comprising phosphorylated amino acids, synthetic phosphorylated peptides, and gastrolith proteins

Publications (1)

Publication Number	Publication Date
DK2211873T3 true DK2211873T3 (da)	2012-11-19

Family

ID=40352818

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK08842462.7T DK2211873T3 (da)	2007-10-22	2008-10-22	Stabil, amorf calciumcarbonat, der omfatter phosphorylerede aminosyrer

Country Status (9)

Country	Link
US (3)	US8802160B2 (da)
EP (2)	EP2251018B1 (da)
JP (2)	JP5453283B2 (da)
CN (2)	CN101969962B (da)
CA (1)	CA2703111C (da)
DK (1)	DK2211873T3 (da)
ES (2)	ES2528901T3 (da)
PL (1)	PL2211873T3 (da)
WO (1)	WO2009053967A1 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL2211873T3 (pl) *	2007-10-22	2013-01-31	Amorphical Ltd	Stabilny amorficzny węglan wapnia wchodzący w skład fosforylowanych aminokwasów
EP2598579B1 (de)	2010-07-30	2024-09-11	Schaefer Kalk GmbH & Co. KG	Kugelförmige, amorphe calciumcarbonat-teilchen
KR101065118B1 (ko)	2011-04-29	2011-09-16	한국지질자원연구원	비정질 탄산칼슘의 형성과 상전이 특성을 분석하는 방법
JP5639551B2 (ja) *	2011-09-13	2014-12-10	株式会社コンカレント	球状炭酸カルシウム微粒子の製造方法
EP2790710B1 (en) *	2011-12-13	2020-08-26	Amorphical Ltd.	Amorphous calcium carbonate for the treatment of calcium malabsorption and metabolic bone disorders
WO2014024191A1 (en) *	2012-08-07	2014-02-13	Amorphical Ltd.	Method for producing stabilized amorphous calcium carbonate
JP2016507553A (ja) *	2013-02-11	2016-03-10	アモーフィカルリミテッド．	骨成長を促進する非晶質炭酸カルシウム
EP3174409A4 (en)	2014-07-31	2018-01-17	Amorphical Ltd.	Encapsulated amorphous calcium carbonate compositions
KR101761133B1 (ko)	2015-03-25	2017-07-26	한국지질자원연구원	탄산칼슘 막 코팅방법
US12121538B2 (en)	2015-06-04	2024-10-22	Amorphical Ltd.	Compositions of amorphous calcium carbonate for inhalation, sublingual or buccal administration
HK1253702A1 (zh)	2015-06-04	2019-06-28	艾玛菲克有限公司	用聚磷酸/聚磷酸酯/聚磷酸盐或双膦酸/双膦酸酯/双膦酸盐稳定的无定形碳酸钙
JP6873389B2 (ja) *	2016-01-18	2021-05-19	アモーフィカルリミテッド．	神経学的、筋肉、および不妊の疾患または症状の治療のための安定化無定形炭酸カルシウム
ES3052833T3 (en)	2016-01-18	2026-01-15	Amorphical Ltd	Stabilized amorphous calcium carbonate as a supplement for cell culture media
JP7152785B2 (ja) *	2016-10-25	2022-10-13	アモーフィカルリミテッド．	白血病治療のための非晶質炭酸カルシウム
CN108358229B (zh) *	2018-03-12	2021-09-10	兰州生物技术开发有限公司	一种以重组胶原蛋白为生物矿化模板制备微孔CaCO3纳米粒子的方法
CN108888600B (zh) *	2018-07-27	2021-06-08	西北大学	一种基于碳酸钙配位螯合药物的pH敏感纳米药物及制备方法和应用
CN119264211A (zh)	2018-08-27	2025-01-07	瑞泽恩制药公司	拉曼光谱在下游纯化中的应用
IL289237B2 (en)	2019-07-23	2026-03-01	Amorphical Ltd	Amorphous calcium carbonate for improving athletic performance
WO2021072392A1 (en) *	2019-10-10	2021-04-15	The Research Foundation For The State University Of New York	Analgesic and anesthetic peptides and other agents
WO2021181372A1 (en) *	2020-03-11	2021-09-16	Amorphical Ltd.	Amorphous calcium carbonate for treatment of acidosis
EP4719439A1 (en) *	2023-05-30	2026-04-08	Amorphical Ltd.	Amorphous calcium carbonate for prevention and treatment of myocardial ischemia
CN116636494B (zh) *	2023-06-08	2026-04-17	广西壮族自治区水产科学研究院	一种澳洲淡水龙虾同步产卵亲本筛选设备及其筛选方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4237147A (en) *	1974-01-04	1980-12-02	Monsanto Company	Stabilized amorphous calcium carbonate
US4964894A (en) *	1986-03-31	1990-10-23	Freepons Donald E	Plant growth regulators derived from chitin
DE3853422T2 (de) *	1988-06-09	1995-10-26	Innogenetics Nv	HIV-3-Retrovirus und seine Verwendung.
US6348571B1 (en) *	1994-09-12	2002-02-19	Northwestern University	Corticotropin release inhibiting factor and methods of using same
CA2567972C (en)	2004-05-26	2015-07-28	Ben-Gurion University Of The Negev Research And Development Authority	Orally-administrable compositions comprising stable amorphous calcium carbonate
SG158153A1 (en) *	2004-12-21	2010-01-29	Musc Found For Res Dev	Compositions and methods for promoting wound healing and tissue regeneration
AU2007207429A1 (en) *	2006-01-19	2007-07-26	Warsaw Orthopedic, Inc.	Injectable and moldable bone substitute materials
IL178495A (en) *	2006-10-05	2014-12-31	Univ Ben Gurion	Use of cancerous gastric components or artificial calcium containing carbonate, chitin and polypeptide preparations to treat calcium metabolism-related or calcium-signaling conditions
PL2211873T3 (pl) *	2007-10-22	2013-01-31	Amorphical Ltd	Stabilny amorficzny węglan wapnia wchodzący w skład fosforylowanych aminokwasów

2008
- 2008-10-22 PL PL08842462T patent/PL2211873T3/pl unknown
- 2008-10-22 EP EP10163143.0A patent/EP2251018B1/en active Active
- 2008-10-22 JP JP2010530627A patent/JP5453283B2/ja active Active
- 2008-10-22 DK DK08842462.7T patent/DK2211873T3/da active
- 2008-10-22 ES ES10163143.0T patent/ES2528901T3/es active Active
- 2008-10-22 CN CN200880113395.9A patent/CN101969962B/zh active Active
- 2008-10-22 ES ES08842462T patent/ES2393041T3/es active Active
- 2008-10-22 WO PCT/IL2008/001362 patent/WO2009053967A1/en not_active Ceased
- 2008-10-22 EP EP08842462A patent/EP2211873B1/en active Active
- 2008-10-22 CA CA2703111A patent/CA2703111C/en active Active
- 2008-10-22 US US12/739,071 patent/US8802160B2/en active Active
- 2008-10-22 CN CN201410482592.5A patent/CN104530208B/zh active Active
2010
- 2010-04-22 US US12/765,009 patent/US20100221362A1/en not_active Abandoned
2013
- 2013-12-26 JP JP2013269224A patent/JP5902145B2/ja not_active Expired - Fee Related
2015
- 2015-06-19 US US14/744,726 patent/US10328100B2/en active Active

Also Published As

Publication number	Publication date
CN104530208B (zh)	2018-12-14
JP5453283B2 (ja)	2014-03-26
JP2014061006A (ja)	2014-04-10
US10328100B2 (en)	2019-06-25
US20100310677A1 (en)	2010-12-09
PL2211873T3 (pl)	2013-01-31
WO2009053967A1 (en)	2009-04-30
EP2251018B1 (en)	2014-12-17
CA2703111C (en)	2016-11-29
EP2251018A3 (en)	2010-11-24
EP2211873B1 (en)	2012-08-08
JP5902145B2 (ja)	2016-04-13
HK1209429A1 (en)	2016-04-01
JP2011501676A (ja)	2011-01-13
CN101969962B (zh)	2014-10-22
EP2211873A1 (en)	2010-08-04
EP2251018A2 (en)	2010-11-17
CN101969962A (zh)	2011-02-09
CA2703111A1 (en)	2009-04-30
US20160045546A1 (en)	2016-02-18
ES2393041T3 (es)	2012-12-18
US8802160B2 (en)	2014-08-12
US20100221362A1 (en)	2010-09-02
ES2528901T3 (es)	2015-02-13
CN104530208A (zh)	2015-04-22

Publication	Publication Date	Title
DK2211873T3 (da)	2012-11-19	Stabil, amorf calciumcarbonat, der omfatter phosphorylerede aminosyrer
NL300962I1 (nl)	2018-12-28	patiromer sorbitex calcium
EP2214542A4 (en)	2014-03-12	ELECTROMANUAL DISPENSER
BRPI0923786A2 (pt)	2016-07-26	compostos 5,6-dihidro-6-fenilbenzo(f) isoquinolina-2- amina substituidos
PT2097111E (pt)	2015-11-03	Heterodímeros de ácido glutámico
TWI367954B (en)	2012-07-11	Evaporation source
EP2121716A4 (en)	2013-06-12	COMPOSITIONS OF STABLE TIACUMICINES
BRPI0912099A2 (pt)	2015-10-06	preparação percutaneamente absorvível
FI20065652A0 (fi)	2006-10-12	Jallkine
BRPI0912798A2 (pt)	2015-10-13	parte de distribuidor
BRPI0814800A2 (pt)	2015-02-03	Derivados de aminoácidos
FR2932687B1 (fr)	2010-09-17	Biomateriaux a base de phosphates de calcium.
NL1031397A1 (nl)	2006-05-08	Samenstelling omvattende desmopressine.
DE602007004709D1 (de)	2010-03-25	Protokoll zur Vorwärtsregelung
FR2925058B1 (fr)	2010-10-01	Maltitol parallelepipede rectangulaire.
ITVI20060206A1 (it)	2008-01-06	Imbragatura per calzature
ES1065210Y (es)	2007-10-01	Cultivador de intercepas para viñedos
ES1069235Y (es)	2009-05-28	Calzado
ES1065223Y (es)	2007-10-01	Calzado
ES1063530Y (es)	2007-02-01	Calzado
ES1063616Y (es)	2007-02-16	Calzado
ES1063189Y (es)	2007-01-01	Calzado integral multitalla
IL186850A0 (en)	2008-11-03	Amorphous calcium carbonate comprising gap proteins
FI7705U1 (fi)	2007-11-30	Peliohjainteline
ES1066264Y (es)	2008-04-01	Calzado perfeccionado